Psychopharmacology of Pediatric Anxiety Disorders: A Narrative Review

被引:6
|
作者
Amray, Afshan N. [1 ,2 ]
Munir, Khurram [3 ]
Jahan, Nusrat [4 ]
Motiwala, Fatima B. [5 ]
Naveed, Sadiq [6 ]
机构
[1] Dow Univ Hlth Sci, Dow Med Coll, Med, Karachi, Pakistan
[2] Dow Univ Hlth Sci, Civil Hosp Karachi, Karachi, Pakistan
[3] Sheikh Zayed, Physiol, Rahim Yar Khan, Pakistan
[4] Rush Univ, Internal Med, Med Ctr, Chicago, IL 60612 USA
[5] Texas Tech Univ, Hlth Sci Ctr, Psychiat, Midland, TX USA
[6] Univ Kansas, Med Ctr, Psychiat, Kansas City, MO USA
关键词
anxiety; youth; psychopharmacology; PREPUBERTAL CHILDREN; CONTROLLED-TRIAL; SOCIAL PHOBIA; ADOLESCENTS; CHILDHOOD; PLACEBO; SERTRALINE; VENLAFAXINE; PAROXETINE; CLONAZEPAM;
D O I
10.7759/cureus.5487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anxiety disorders are common among children and adolescents; almost one-third of this population has an anxiety disorder. The most common anxiety disorders in this population are specific phobia (19.3%), social anxiety disorder/social phobia (9.1 %), and separation anxiety disorder (7.6 %). Pediatric anxiety disorders are often associated with poor psychosocial functioning, academic underachievement, learning difficulties, substance abuse, relationship problems, and suicide behaviors. Psychotherapy, particularly cognitive behavioral therapy as a stand-alone treatment or in combination with medication, is found to be efficacious in the treatment of various anxiety disorders. The early recognition and treatment of anxiety disorders result in better long-term outcomes in children and adolescents. This article summarizes the evidence-based pharmacologic treatments for anxiety disorders in youth, including social anxiety disorder generalized anxiety disorder, separation anxiety disorder, and panic disorder.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review
    Wang, Daoxi
    Tang, Xueyang
    Shi, Qianyu
    Wang, Ruifeng
    Ji, Tao
    Tang, Xiaodong
    Guo, Wei
    [J]. TRANSLATIONAL PEDIATRICS, 2023, 12 (03) : 470 - +
  • [32] The new guidelines from the British Association for Psychopharmacology for anxiety disorders
    Anderson, Ian
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2006, 10 : 10 - 17
  • [33] Pediatric Sleep Respiratory Disorders: A Narrative Review of Epidemiology and Risk Factors
    Piotto, Marta
    Gambadauro, Antonella
    Rocchi, Alessia
    Lelii, Mara
    Madini, Barbara
    Cerrato, Lucia
    Chironi, Federica
    Belhaj, Youssra
    Patria, Maria Francesca
    [J]. CHILDREN-BASEL, 2023, 10 (06):
  • [34] A review of the growing evidence base for pediatric psychopharmacology
    Pappadopulos, EA
    Guelzow, BT
    Wong, C
    Ortega, M
    Jensen, PS
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2004, 13 (04) : 817 - +
  • [35] The psychopharmacology of anxiety
    Nutt, DJ
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 1996, 55 (04): : 187 - 191
  • [36] PEDIATRIC PSYCHOPHARMACOLOGY - REVIEW WITH SPECIAL REFERENCE TO DEANOL
    OETTINGER, L
    [J]. DISEASES OF THE NERVOUS SYSTEM, 1977, 38 (12): : 25 - 31
  • [37] OVERVIEW OF PEDIATRIC ANXIETY DISORDERS
    Walkup, John T.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S150 - S151
  • [38] PHARMACOGENOMICS OF PEDIATRIC ANXIETY DISORDERS
    Ramsey, Laura B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S151 - S152
  • [39] Anxiety Disorders in Pediatric Oncology
    Zemzem, M.
    Chabchoub, I.
    Ben Ahmed, T.
    Horchen, M.
    Ben Ahmed, S.
    Hamza, M.
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 : S643 - S643
  • [40] PEDIATRIC MANAGEMENT OF ANXIETY DISORDERS
    MATTISON, RE
    [J]. PEDIATRIC ANNALS, 1989, 18 (02): : 114 - &